Role of Elastin Metabolites in Aortic Remodelling in AS

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Aortic Stenosis
Interventions
DIAGNOSTIC_TEST

ECG

A 12-lead ECG will be taken for each participant.

DIAGNOSTIC_TEST

Blood test and biobanking

All patients will undergo venepuncture and blood sample will be taken for full blood count, renal function and plasma will be stored for future biomarker analysis.

DIAGNOSTIC_TEST

Trans-thoracic Echocardiogram

A standard TTE will be undertaken to measure severity of AS as well as bi-ventricular function. Speckle-tracking data will be performed offline to assess diastolic function.

DIAGNOSTIC_TEST

Vicorder recording

Measurement of carotid-femoral PWV will be made using the Vicorder technique.

DIAGNOSTIC_TEST

Magnetic Resonance Imaging

Patients will undergo a stress MRI scan of their heart and aorta on a 3T scanner, including 4D flow.

Trial Locations (1)

Unknown

University Hospitals of Leicester NHS Trust, Leicester

All Listed Sponsors
lead

University of Leicester

OTHER

NCT03883490 - Role of Elastin Metabolites in Aortic Remodelling in AS | Biotech Hunter | Biotech Hunter